Inmazeb ebola therapeutics

Active Definitive Contract Awarded Last action

Contract number
HHSO100201700016C
Awardee
Awarding agency
Obligated
$973,560,407

Award facts

Opportunity
  • 17100SOL00014 Solicitation number
  • Ebola Therapeutics Award Notice · Posted Apr 18, 2017
Contract value 94% obligated
  • $973,560,406.91 Current, with exercised options
  • $1,036,922,154.91 Potential, with all options
Completion date 65% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Sleepy Hollow, NY 10591, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00018 $277,818,931
Change Order P00017 $2,684,549
Change Order P00016 · No cost MOD to revise the contract sections: article b.4 and f.4 $0
Change Order P00015 · No cost MOD to revise the contract sections: article b.2.1., article c.1., article f.4, , article g.4. And the statement of work. $0
Other Administrative Action P00014 · No cost MOD to revise the contract sections: article b.2.2., b.4.q., article c.1., article f.4, and the statement of work. Add article b.4.r., article h.31.,… $0
Change Order P00013 $0
Supplemental Agreement for work within scope P00011 $0
Change Order P00010 $0
Other Administrative Action P00009 $0
Exercise an Option P00008 $344,581,000
Other Administrative Action P00007 -$67,856
Supplemental Agreement for work within scope P00006 $47,277,219
Other Administrative Action P00005 · Ebola therapeutics $22,824,430
Exercise an Option P00004 $131,811,954
Other Administrative Action 3 $52,635,588
Exercise an Option 2 $25,896,179
Exercise an Option 1 $27,653,801
Original award $40,444,612
Show all 18

About this award

Written by GovTribe AI ·

The Office of the Assistant Secretary for Preparedness and Response awarded a $1.036 billion definitive contract to Regeneron Pharmaceuticals Inc. for INMAZEB Ebola therapeutics on September 30, 2017, under a cost-plus-fixed-fee pricing structure with no set-aside.

Place of performance is Sleepy Hollow, NY. The contract extends through September 29, 2031. In fiscal year 2024, Regeneron invoiced $140.3 million against the contract across 2.7 FTEs and 5,595 contractor hours, yielding a derived government-paid hourly rate of $25,077.69 per hour. The prime self-performed all reported labor with no subcontractors.

Quick answers

Who was awarded contract HHSO100201700016C?

HHSO100201700016C was awarded to Regeneron Pharmaceuticals Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 30, 2017.

How much is contract HHSO100201700016C worth?

The government has obligated $973,560,407 on HHSO100201700016C. Its potential value, with all options, is $1,036,922,155.

Was contract HHSO100201700016C competed?

The extent of competition for HHSO100201700016C was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login